Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trial.

European journal of heart failure·2026
Same author

The Role of Finerenone in Cardiorenal Protection and Urine Albumin-to-Creatinine Ratio Modulation.

Kidney international reports·2026
Same author

Effect of Finerenone Treatment Discontinuation on Kidney and Cardiovascular Outcomes: A Fidelity Analysis.

American journal of nephrology·2026
Same author

Tackling Therapeutic Inertia on Mineralocorticoid Receptor Antagonist Adoption in Heart Failure.

The Journal of the Association of Physicians of India·2026
Same author

Ruptured intracranial dermoid cysts: Imaging at acute presentation and follow-up.

Emergency radiology·2026
Same author

Photoflow Sulfur Alkylation of Sulfenamides for Direct Access of <i>S</i>-Methyl Sulfoximines.

The Journal of organic chemistry·2026

Related Experiment Videos

Hypertension in the developing world: challenges and opportunities.

Bharati V Mittal1, Ajay K Singh

  • 1Renal Division, Brigham & Women's Hospital and Harvard Medical School Dubai Center Institute of Postgraduate Education and Research, Dubai, UAE.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|December 8, 2009
PubMed
Summary

Hypertension affects one-quarter of adults globally, with numbers projected to rise significantly in developing nations. Public health efforts must focus on awareness, risk factors, and lifestyle changes for effective hypertension management.

Related Experiment Videos

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiovascular Disease

Background:

  • Hypertension is a significant global health issue, particularly in developing countries.
  • It is a leading cause of death and disability worldwide.
  • Prevalence is projected to increase, reaching 1.15 billion by 2025.

Purpose of the Study:

  • To highlight the growing burden of hypertension in developing countries.
  • To examine the heterogeneity in global hypertension prevalence.
  • To underscore the need for improved awareness and management strategies.

Main Methods:

  • Analysis of global hypertension prevalence data.
  • Identification of factors contributing to prevalence variations.
  • Review of current public health challenges and responses.

Main Results:

  • Approximately 35% of the Latin American population has hypertension.
  • Prevalence ranges from 20%-30% in China and India, and 14% in Sub-Saharan Africa.
  • Factors like urbanization, lifestyle, ethnicity, and birth weight influence prevalence.

Conclusions:

  • There is a critical need for increased awareness and effective treatment of hypertension.
  • Multifaceted strategies are essential for managing hypertension in developing nations.
  • Further research into risk factors and lifestyle impacts is crucial.